The Investigational Drug

For the PROSEEK Study, the investigational drug is being studied to see if it may slow the progression of Parkinson’s disease. It is designed to block a specific enzyme (biological molecules that help to accelerate chemical reactions in the body) called “Abl.” Research has shown that overactivation of Abl may play a role in Parkinson’s disease progression. Therefore, by limiting or blocking Abl, it may be possible to help slow PD progression.